XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Millions
Total
COMMON STOCK
ADDITIONAL PAID-IN CAPITAL
RETAINED EARNINGS
ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME
TREASURY SHARES
NON-CONTROLLING INTERESTS
Balance, beginning of period at Dec. 31, 2020   $ 561 $ 943 $ 16,272 $ (5,110) $ (3,562) $ 156
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (48)        
Issuance of shares under stock compensation plans and employee stock purchase plans     50     154  
Net income attributable to the Company $ 1,825     1,803     22
Dividend equivalents declared       (6)      
Dividends declared       (472)      
Other comprehensive (loss) income, net of tax (43)       (43)    
Purchase of treasury shares (445)         (434)  
Distributions and other changes             (22)
Balance, end of period at Jun. 30, 2021 $ 10,264 561 945 17,597 (5,153) (3,842) 156
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 0.930            
Balance, beginning of period at Mar. 31, 2021   561 851 16,780 (5,197) (3,561) 162
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     85        
Issuance of shares under stock compensation plans and employee stock purchase plans     9     41  
Net income attributable to the Company $ 827     820     7
Dividend equivalents declared       (3)      
Dividends declared       0      
Other comprehensive (loss) income, net of tax 44       44    
Purchase of treasury shares           (322)  
Distributions and other changes             (13)
Balance, end of period at Jun. 30, 2021 $ 10,264 561 945 17,597 (5,153) (3,842) 156
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 0.465            
Balance, beginning of period at Dec. 31, 2021 $ 11,222 561 1,112 18,389 (4,575) (4,478) 213
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (140)        
Issuance of shares under stock compensation plans and employee stock purchase plans     72     149  
Net income attributable to the Company 2,064     2,038     26
Dividend equivalents declared       (7)      
Dividends declared       (540)      
Other comprehensive (loss) income, net of tax (788)       (788)    
Purchase of treasury shares (1,100)         (1,100)  
Distributions and other changes             (15)
Balance, end of period at Jun. 30, 2022 $ 10,917 561 1,044 19,880 (5,363) (5,429) 224
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 1.070            
Balance, beginning of period at Mar. 31, 2022   561 1,026 18,916 (4,679) (4,887) 219
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     5        
Issuance of shares under stock compensation plans and employee stock purchase plans     13     58  
Net income attributable to the Company $ 978     967     11
Dividend equivalents declared       (3)      
Dividends declared       0      
Other comprehensive (loss) income, net of tax (684)       (684)    
Purchase of treasury shares           (600)  
Distributions and other changes             (6)
Balance, end of period at Jun. 30, 2022 $ 10,917 $ 561 $ 1,044 $ 19,880 $ (5,363) $ (5,429) $ 224
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 0.535